Roland Wandeler

Corporate Officer/Principal presso GRIFOLS, S.A.

53 anni

Health Technology

Consumer Services

Profilo

Dr. Roland Wandeler is a President-Biopharma Business Unit at Grifols SA. Dr. Wandeler was previously employed as a Chief Executive Officer by Encinal Bio, Inc., a Chief Operating Officer by MorphoSys AG, and a VP, GM-US Bone Health & Cardiology Business Unit by Amgen, Inc. He received his graduate degree from Swiss Federal Institute of Technology and a doctorate degree from Swiss Federal Institute of Technology.

Posizioni attive di Roland Wandeler

Società	Posizione	Inizio
GRIFOLS, S.A.	Corporate Officer/Principal	01/01/2024

Tutte le posizioni attive di Roland Wandeler

Precedenti posizioni note di Roland Wandeler

Società	Posizione	Fine
Encinal Bio, Inc.	Amministratore Delegato	01/10/2023
MORPHOSYS AG	Direttore operativo	31/12/2021
AMGEN INC.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Roland Wandeler

Formazione di Roland Wandeler

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Roland Wandeler

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	5
Amgen, Inc. Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics	Health Technology
Grifols SA Grifols SA Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceuticals, diagnostic and bio supplies	Health Technology
MorphoSys AG MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services	Health Technology
Swiss Federal Institute of Technology Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Encinal Bio, Inc.